-
What is the Marburg virus and how does it spread?
The Marburg virus is a highly infectious virus that causes severe hemorrhagic fever, similar to Ebola. It spreads through direct contact with bodily fluids of infected individuals, including blood, saliva, and sweat. The virus can also be transmitted through contaminated surfaces and materials.
-
What measures are being taken in Rwanda to control the outbreak?
In response to the outbreak, Rwandan authorities have implemented strict hygiene protocols, including enhanced sanitation in healthcare facilities and public awareness campaigns. Contact tracing is actively being conducted to identify and isolate individuals who may have been exposed to the virus.
-
Who is most at risk during this outbreak?
Healthcare workers are at the highest risk during this outbreak, as they are often the first to come into contact with infected patients. Additionally, individuals who have close contact with confirmed cases or who are involved in burial practices may also be at increased risk.
-
What are the symptoms of Marburg virus infection?
Symptoms of Marburg virus infection typically appear 2 to 21 days after exposure and can include high fever, severe headache, muscle pain, and gastrointestinal symptoms such as vomiting and diarrhea. As the disease progresses, it can lead to severe bleeding and organ failure.
-
What is the fatality rate of the Marburg virus?
The Marburg virus has a high fatality rate, often ranging from 23% to 90% in past outbreaks, depending on the virus strain and the quality of medical care available. The current outbreak in Rwanda has already resulted in several fatalities, highlighting the urgency of the situation.
-
Are there any treatments available for Marburg virus?
Currently, there are no approved treatments specifically for Marburg virus infection. Supportive care, including hydration and symptomatic treatment, is crucial for improving survival rates. Research is ongoing to develop effective therapies and vaccines.